<SEC-DOCUMENT>0001213900-22-053474-index.html : 20220902
<SEC-HEADER>0001213900-22-053474.hdr.sgml : 20220902
<ACCEPTANCE-DATETIME>20220902090130
ACCESSION NUMBER:		0001213900-22-053474
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20220902
FILED AS OF DATE:		20220902
DATE AS OF CHANGE:		20220902

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PolyPid Ltd.
		CENTRAL INDEX KEY:			0001611842
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38428
		FILM NUMBER:		221223336

	BUSINESS ADDRESS:	
		STREET 1:		18 HASIVIM STREET
		CITY:			PETACH TIKVA
		STATE:			L3
		ZIP:			495376
		BUSINESS PHONE:		972-74-7195700

	MAIL ADDRESS:	
		STREET 1:		18 HASIVIM STREET
		CITY:			PETACH TIKVA
		STATE:			L3
		ZIP:			495376
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea165323-6k_polypid.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
Document 1 - file: ea165323-6k_polypid.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea165323ex99-1_polypid.htm
<DESCRIPTION>PRESS RELEASE ISSUED BY POLYPID LTD. ON SEPTEMBER 2, 2022, TITLED "POLYPID ANNOUNCES TOP-LINE RESULTS OF PHASE 3 SHIELD I TRIAL OF D-PLEX100 FOR PREVENTION OF SURGICAL SITE INFECTIONS IN ABDOMINAL SURGERY."
<TEXT>
Document 2 - file: ea165323ex99-1_polypid.htm

</DOCUMENT>
</SEC-DOCUMENT>